Replies to post #723819 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

flipper44,

Just that wording would have helped clear up all the early speculation about rapid approval. Evidently NWBO knew they needed to keep interest alive a little longer with hopes for an earlier approval so they kept it nebulous. It’s what they don’t say that is very often more important. Best wishes.

[dennisdave]

do you know if the MHRA has recently (this year) made public they are behind in their drug approval process?

ChatGPT
Yes, the MHRA has acknowledged challenges related to its drug approval process in 2023. There have been reports indicating delays in the evaluation of new medicines and the regulatory review process. Factors contributing to these delays include increased workload, the complexity of submissions, and resource constraints.

The agency has been working on measures to improve efficiency and speed up the approval process, but the situation has drawn attention and concern from stakeholders in the pharmaceutical industry. For the latest updates or specific announcements, it's always a good idea to check the MHRA's official website or recent press releases.